WO2010140816A2 - Beoseon destinée à une stimulation par microcourant - Google Patents

Beoseon destinée à une stimulation par microcourant Download PDF

Info

Publication number
WO2010140816A2
WO2010140816A2 PCT/KR2010/003505 KR2010003505W WO2010140816A2 WO 2010140816 A2 WO2010140816 A2 WO 2010140816A2 KR 2010003505 W KR2010003505 W KR 2010003505W WO 2010140816 A2 WO2010140816 A2 WO 2010140816A2
Authority
WO
WIPO (PCT)
Prior art keywords
microcurrent
control signal
human body
level
voltage
Prior art date
Application number
PCT/KR2010/003505
Other languages
English (en)
Korean (ko)
Other versions
WO2010140816A3 (fr
Inventor
이지훈
Original Assignee
Lee Ji Hun
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020100051318A external-priority patent/KR101235789B1/ko
Application filed by Lee Ji Hun filed Critical Lee Ji Hun
Publication of WO2010140816A2 publication Critical patent/WO2010140816A2/fr
Publication of WO2010140816A3 publication Critical patent/WO2010140816A3/fr

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/322—Electromedical brushes, combs, massage devices

Definitions

  • the present invention relates to a socks worn on the foot of the human body to be used for treatment or massage purposes, and more specifically, microcurrent stimulation that can increase the effect of massage or treatment by stimulating by delivering a microcurrent to the foot of the human body. It is about dragon socks.
  • the foot is the body part located at the end of the leg, which is a delicate human organ with 26 bones, 39 joints, 38 muscles, 107 ligaments, and many other capillaries and autonomic nerves. These feet have two pulses, one on the instep and one on the Achilles tendon, and acupuncture points that cover 63 parts of the human body. In addition, the foot is a very important role and function of the human body, such as maintaining the balance of the body, weight support, shock absorption, movement.
  • the most important function of the foot function is the walking function, the pump function of the foot.
  • the pump function of the foot is to help the heart to promote blood circulation and metabolism. Since the position of the heart is higher from the ground since humans start walking upright, the blood circulation becomes more difficult as the blood circulation becomes more difficult. Pump function should be smooth. Thus, the foot is also referred to as the second heart function.
  • Diabetes is known to be caused by changes in diet, bad drinking culture, and lack of exercise caused by modern people's busy schedules.
  • the appearance of diabetes initially causes problems throughout the body, but gradually causes nerves, blood vessels, and the immune system to break down, and nerves are gradually destroyed and blood vessels become clogged, causing the most serious problems in the foot at the end of the body.
  • 15-20% of patients hospitalized with diabetes may show foot ulcers. Foot ulcers are a major obstacle in diabetics, ranging from 28% to amputation, which is astronomical.
  • Diabetic foot disease which is caused by a combination of microvascular disorders, free radicals and glycation of proteins due to prolonged hyperglycemia, includes abnormalities, necrosis, calluses, and refractory athlete's foot. If you have diabetes, your feet will be easily injured. If you are infected with a wound, you will not be treated well, unlike a healthy person, and will gradually spread to the upper part.If you miss the initial treatment period, the disease will progress rapidly and irreversibly. Can cause. In addition, as diabetes progresses, most patients have neuropathy, which is a symptom of sensory neuropathy at the extremities of the lower extremities, resulting in cold, numb, and burning symptoms.
  • the present invention has been devised in view of the above, it is worn on the foot of the human body by passing a micro current to the soles, instep, ankle, microcurrent stimulation socks that can achieve an effective foot massage effect or treatment effect
  • the purpose is to provide.
  • Microcurrent stimulation tab of the present invention for achieving the above object
  • Endothelial and outer shell formed in the shape of a human foot and made of an insulator material; An air filling space formed between the endothelium and the outer shell; An air injection unit connected to the air filling space through a hose to inject air into the air filling space; A plurality of magnetic pole members attached to the inner surface of the endothelium and made of a conductive material; And a microcurrent generator electrically connected to the plurality of magnetic pole members to supply a microcurrent to the magnetic pole members.
  • the magnetic pole member is formed of any one of a conductive rubber, a conductive metal, a conductive fabric, characterized in that attached to the inner surface of the endothelium.
  • the microcurrent generator The microcurrent generator
  • Control unit for controlling the;
  • a booster boosting a power supply voltage to a boosted voltage of a predetermined level in response to the third control signal of the control unit;
  • a microcurrent having a desired level is generated and supplied to a specific part of the human body through connection terminals connected to the human body, and when the first control signal is input, And a microcurrent output unit for supplying the microcurrent having a phase and supplying the microcurrent having a negative phase when the second control signal is input.
  • the microcurrent output unit includes at least one voltage distribution circuit and a plurality of switching elements, and each of the plurality of switching elements performs a switching operation in response to the first control signal or the second control signal. .
  • the microcurrent output unit generates and supplies a supply level confirmation signal for confirming a human supply level of the microcurrent supplied to the human body, and provides the control unit, and the control unit generates a boosted voltage in response to the supply level confirmation signal. Characterized by controlling the level.
  • the first control signal and the second control signal is a pulse signal having a predetermined period and a certain duty ratio, characterized in that the first control signal and the second control signal has a predetermined phase difference.
  • the control unit checks whether the human body connection terminals are actually connected to the human body through the supply level confirmation signal, and controls whether or not a microcurrent is generated.
  • the present invention as described above, there is an advantage that the massage effect or therapeutic effect can be more effectively implemented by transferring a microcurrent to the sole, instep, ankle in the state wearing the socks on the foot of the human body.
  • FIG. 1 is a perspective view illustrating a microcurrent stimulating wire in accordance with an embodiment of the present invention.
  • Figure 2 is a cross-sectional view showing the microcurrent stimulation tabine according to an embodiment of the present invention.
  • FIG. 3 is an enlarged cross-sectional view of a portion A of FIG. 2.
  • Figure 4 is a block diagram showing a microcurrent generator applied to the microcurrent stimulation wire of the present invention.
  • FIG. 5 is a circuit diagram of an example of the microcurrent generator of FIG. 4.
  • FIG. 5 is an operation timing diagram of FIG. 5
  • FIG. 7 illustrates another embodiment of the booster of FIG. 4.
  • FIG. 1 to 3 illustrate a microcurrent stimulating wire according to an embodiment of the present invention.
  • the microcurrent stimulating socks of the present invention is composed of the endothelial 11 and the outer shell 12 formed in the shape of the human foot, the endothelial 11 and the outer shell 12 is made of a non-conductive material fiber or synthetic resin It is composed.
  • a zipper 16 is installed at one side of the tabine of the present invention, and the zipper 16 can be very easily worn.
  • An air filling space 13 through which air is injected is formed between the inner shell 11 and the outer shell 12, and the air injection portion 14 is communicatively connected to the air filling space 13 through a hose 13a. .
  • the air injection unit 14 may be configured of various units capable of injecting air into the air filling space 13.
  • the air injection unit 14 injects a certain amount of air into the air filling space 13 when in use, and also discharges the air in the air filling space 13 to the outside when not in use, thereby facilitating its storage or transportation. Can be.
  • the present invention increases the massage effect by the air as the air is injected into the air filling space (13).
  • a plurality of stimulation members 15 are disposed on the inner surface of the endothelium 11, and each stimulus member 15 may be disposed at a position corresponding to the acupoints of the sole, the instep, the ankle, or other positions.
  • the magnetic pole member 15 may be formed of a conductor such as conductive rubber or a conductive metal, and the magnetic pole member 15 of a conductive material may be attached to an inner surface of the inner shell 11 through an adhesive or the like.
  • the microcurrent is transmitted to the sole, instep, ankle, etc. through the stimulus member 15, thereby facilitating metabolism of the cells, and thus the pump function of the foot helps the heart to promote blood circulation and metabolism.
  • the magnetic pole member 15 is composed of a conductive fabric woven or knitted good conductive yarns such as gold yarn, silver, verbs, etc., the magnetic pole member 15 of the conductive fabric is endothelial through a sewing process It can be attached to the inner side of (11).
  • the microcurrent generator 150 is electrically connected to the magnetic pole member 15 so that the microcurrent generated by the microcurrent generator 150 is transmitted to the human body through the magnetic pole member 15.
  • microcurrent of about 0.06 mA flows in the human body, and the strength of the microcurrent varies depending on the state of health. In general, a phenomenon in which the amount of microcurrent flows in a poor state of health is known clinically.
  • the size of the microcurrent is less than 1 ⁇ s to a few hundreds of amps, it may be suitable for the massage or treatment, and it may be desirable that the microcurrent flows intermittently for a certain period of time instead of continuous flow to give electric stimulation. .
  • the microcurrent generated by the microcurrent generator 150 may be transmitted to the acupoints or other parts of the sole, ankle, and instep of the human body through the stimulus member 15 to perform electrical stimulation.
  • the stimulus member 15 attached to the inner surface of the endothelium 11 may be more closely attached to the skin, thereby increasing the effect of the electric stimulation.
  • the plurality of magnetic pole members 15 according to the present invention may be divided into a negative electrode plate and a positive electrode plate, and may further increase the effect of the electrical stimulation by separately transmitting the negative current and the positive electrode current to the skin of the human body. .
  • the microcurrent generator 150 of the present invention includes a control unit 310, a boosting unit 320, and a microcurrent output unit 330.
  • the control unit 310 is a first control signal (S1) for generating a fine current having a positive phase, a second control signal (S2) for generating a fine current having a negative phase, and for boosting the power supply voltage
  • the third control signal S3 is generated to control the generation of the microcurrent.
  • the control unit 310 checks the level of the microcurrent supplied to the human body through the microcurrent generator 150 and controls the third control signal S3 to adjust the level of the boosted voltage when the level is not a predetermined level. By varying, the human body supply level of the microcurrent is controlled.
  • the control unit 310 may include a control chip having a CPU to generate the first to third control signals S1, S2, and S3.
  • the booster 320 boosts the power voltages Vdd and Vcc to a boosted voltage of a predetermined level in response to the third control signal S3 of the control unit 310 to the microcurrent output unit 330. Supply.
  • the booster circuit constituting the booster unit 320 includes a booster circuit of a DC-DC converter type using a back electromotive force of an inductor, a charge pump circuit using a capacitor, and to those skilled in the art.
  • Various well known boost circuits can be used.
  • the microcurrent output unit 330 generates a microcurrent of a desired level based on the boosted voltage boosted by the booster 320 and supplies the microcurrent to the specific site of the human body through contact terminals in contact with the human body. .
  • the microcurrent output unit 330 supplies the microcurrent having a positive phase when the first control signal S1 is input, and a negative phase when the second control signal S2 is input. Supply the microcurrent having a.
  • the microcurrent is a current level of 0 to 1000 mA (not including 0) and refers to the micro current in microamps.
  • the microcurrent output unit 330 is generated by selecting any current level determined to have the highest therapeutic effect or massage effect among the current levels of 0 to 1000 mA (not including 0). For example, a microcurrent of 0 to 300 mA or a micro current of 100 to 150 mA can be output.
  • the microcurrent output unit 330 includes at least one voltage distribution circuit and a plurality of switching elements, and each of the plurality of switching elements may include the first control signal S1 or the first control element.
  • the switching operation may be performed in response to the two control signal S2.
  • the microcurrent can be varied in response to the skin resistance of the human body used to make the level of the microcurrent actually supplied to the human body constant.
  • the microcurrent output unit 330 generates a supply level confirmation signal for confirming the human body supply level of the microcurrent supplied to the human body and provides it to the control unit 310, and the control unit 310 provides the In response to the supply level confirmation signal, the level of the boosted voltage of the booster 320 is controlled.
  • the supply level confirmation signal provides a function for confirming whether the condition for supplying the microcurrent is actually made in contact with the human body in addition to the function for confirming the level of the microcurrent actually supplied to the human body.
  • FIG. 5 is a circuit diagram illustrating an example of implementation of the microcurrent generator of FIG. 4.
  • control unit 310a is a control chip (for example, PIC16F716) (U2), resistor (R4), capacitor (C4), power (Vcc), LED to determine whether the power supply ( Including D2) has a wiring structure as shown in FIG.
  • the control chip U2 may be a generator of a control signal having various kinds of frequencies.
  • control unit 310a may include a first control signal S1 for generating a microcurrent having a positive phase, a second control signal S2 for generating a microcurrent having a negative phase, And generating a third control signal S3 for boosting the power voltage to control the microcurrent generation.
  • control unit 310a receives the supply level confirmation signal MC for confirming the human body supply level of the microcurrent supplied to the human body provided by the microcurrent output unit 330a to receive the booster 320a.
  • the level of the boosted voltage VC can be controlled.
  • the level control of the boosted voltage VC is possible through the third control signal.
  • control unit 310a checks the human body supply level of the microcurrent through the supply level confirmation signal MC, it is also possible to check whether the human body contact terminals P1 and P2 actually contact the human body. . This is because it is possible to determine that the human body contact terminals P1 and P2 are in contact with the human body if the supply level confirmation signal MC is within a range corresponding to the skin resistance because the range of the human body's skin resistance is determined.
  • the body contact terminals P1 and P2 correspond to the magnetic pole member 15.
  • the control unit 310a first checks whether the human body contact terminals P1 and P2 are in contact with the human body through the supply level confirmation signal MC, and whether a microcurrent is generated. It is decided. That is, when it is confirmed that the human body is contacted through the supply level check signal MC, the microcurrent is generated through the microcurrent generator, and then the function of confirming the actual human supply level of the microcurrent is performed.
  • the power supply voltage may be configured to be supplied through a battery.
  • the booster 320a may include a switching element Q7, which is repeatedly switched by the third control signal S3 generated by the control unit 310a, an inductor L1, rectification and ripple prevention, and boost voltage.
  • a diode D1 for storage, capacitors C1 and C2, and a resistor R10 have a wiring structure as shown in FIG. 5.
  • a transistor is used as the switching element Q7, but various switching elements including a MOSFET may be used.
  • the boosting unit 320a may be configured through a boost circuit of a DC-DC converter type having the boost stage 10 formed in multiple stages, and may include various boost circuits such as a boosting circuit. It is possible to implement
  • the microcurrent output unit 330a includes a plurality of voltage dividers using a plurality of resistors R1, R6, R2, R7, R8, and R9 and a plurality of switching elements Q1, Q2, Q3, Q4, Q5, and Q6. ) To output a microcurrent to the human body contact terminals (P1, P2).
  • the plurality of switching elements Q1, Q2, Q3, Q4, Q5, and Q6 use transistors, but various switching elements including MOSFETs may be applied.
  • Some switching elements Q6 and Q3 of the switching elements Q1, Q2, Q3, Q4, Q5 and Q6 are controlled by the first control signal S1, and some switching elements Q5 and Q4 are controlled. Is controlled by the second control signal S2, and the remaining switching elements Q1 and Q2 are controlled by the voltage of the first node n1, that is, the boosted voltage VC.
  • the human body contact terminals P1 and P2 are mounted on specific parts of the human body (sites requiring treatment or massage), and the second human body contacts the microcurrent applied through the first human contact terminal P1 through the human body. It may be configured to return to the terminal (P2), or to allow the micro-current applied through the second human contact terminal (P2) to pass through the human body to return to the first human contact terminal (P1).
  • FIG. 6 is a timing diagram of the control signal and the fine current of FIG. 5.
  • the microcurrent generator 150 operates while the human body contact terminals P1 and P2 of the microcurrent generator 330a of the microcurrent generator 150 are mounted on a specific part of the human body.
  • control unit 310a When power is supplied through a battery, the control unit 310a generates a signal for confirming whether the human body is in contact with the microcurrent output unit 330a or the third control signal S3 for generating a general microcurrent. In addition, the supply level confirmation signal MC is received to check whether the human body contact terminals P1 and P2 actually touch the human body.
  • control unit 110a supplies the third control signal S3 for generating a microcurrent to the boosting unit 320a.
  • the third control signal S3 is a control signal whose width and period are adjusted for boosting.
  • the control unit 310a supplies the third control signal S3 to the boosting unit 320a.
  • the third control signal S3 is a control signal whose width and period are adjusted for boosting.
  • the switching element Q7 of the boosting unit 320a is turned on / off in response to the third control signal S3.
  • a forward bias is applied to the diode D2, and the capacitor C2 stores a voltage output through the diode D2, and the voltage of the output voltage, that is, the boosted voltage VC, is on. Eliminate pulsations (ripples).
  • the first node n1 Generates a boosted voltage VC several times to several ten times higher than the power supply voltages Vcc and Vdd. For example, assuming that the power supply voltage is 3V, it is possible to obtain a voltage of 30V. Of course, it is also possible to generate higher levels of voltage.
  • the switching device Q7 when the switching device Q7 repeatedly performs the on / off operation according to the width and the period of the third control signal S3 of the control unit 310a, the boosted voltage VC has a desired level. .
  • the control unit 310a When the boosted voltage VC reaches a desired level, the control unit 310a generates a first control signal S1 and a second control signal S2.
  • the first control signal S1 and the second control signal S2 may be generated at the same time as the supply of the power supply voltage of the control unit 310a, but it does not mean that the boosted voltage VC reaches a desired level. Therefore, it is assumed here that it occurs when the boosted voltage VC reaches a desired level.
  • the first control signal S1 is for generating a micro current having a positive phase
  • the second control signal S2 is for generating a micro current having a negative phase.
  • the first control signal S1 is shown in FIG. 6. It may have a waveform structure of the pulse (pulse) having a certain period and a certain duty ratio (duty ratio). For example, it may have a waveform structure having a period of 1 second and a constant voltage level for a time of 150 ms, and a voltage level of 0 for the remaining time.
  • the period or duty ratio may be changed by a unit of time, and the period or duty ratio may have a different waveform structure.
  • the second control signal S2 may have a waveform structure in the form of a pulse having a certain period and a constant duty ratio in a form having a predetermined phase difference from the first control signal S1.
  • the second control signal S2 has the same shape except that it has a predetermined phase difference from the first control signal S1.
  • the second control signal S2 should have a voltage level of 0 in a time interval t1 in which the first control signal S1 has a constant voltage level, and the first control signal S1 has a voltage of 0.
  • the waveform structure has a constant voltage level.
  • the pulse of the first control signal S1 and the pulse of the second control signal S2 are generated so as not to overlap. That is, the timing at which the switching elements Q6 and Q3 are turned on by the first control signal S1 and the timing at which the switching elements Q5 and Q4 are turned on by the second control signal S2 should be different. Immediately after the switching elements Q6 and Q3 are turned on by the first control signal S1 and turned off again, the switching elements Q5 and Q4 are turned on by the second control signal S2. Also, the switching elements Q6 and Q3 are turned on by the first control signal S1 and then turned off again, and after a predetermined time, the switching elements Q5 and Q4 are turned on by the second control signal S2. It is also possible to turn on. This is possible by controlling the timing of the pulse generation of the second control signal S2, and may be determined differently as necessary in consideration of treatment or massage effects.
  • the microcurrent output unit 330a turns on the switching element Q1 by the voltage divided by the voltage distribution of the resistors R1 and R6.
  • the voltage divided by the voltage distribution of R2 and R7 turns on the switching element Q2. This is possible when the switching elements Q5 and Q6 are turned off.
  • the switching element Q6 is turned on by the first control signal S1 even when the boost voltage VC reaches a predetermined level.
  • the switching device Q2 is turned on and the switching device Q1 is turned off and the switching device Q5 is turned on by the second control signal S2, the switching device Q1 is turned on and switched. Element Q2 is turned off.
  • the switching device Q2 When the switching devices Q6 and Q3 are turned on by the first control signal S1 and the switching devices Q5 and Q4 are turned off by the second control signal S2, the switching device Q2. ) Is turned on, and the microcurrent is supplied to the human body through the switching element Q2 and the human body contact terminal P1 at the first node n1, and the microcurrent supplied to the human body is the human body contact terminal P2 and It is recovered through the switching element Q3 and the resistors R8 and R9. At this time, the switching elements Q5, Q4, and Q1 are turned off by the second control signal S2. At this time, the microcurrent supplied to the human body has a positive phase, as shown in the microcurrent graphs P1-P2 of FIG. 6.
  • the switching devices Q6 and Q3 are turned off by the first control signal S1 and the switching devices Q5 and Q4 are turned on by the second control signal S2, the switching device Q1.
  • the microcurrent is supplied to the human body through the switching element Q1 and the human body contact terminal P2 at the first node, and the microcurrent supplied to the human body is the human body contact terminal P1 and the switching element ( Q4), it is recovered through the resistors R8 and R9.
  • the switching elements Q6, Q3, and Q2 are turned off by the first control signal S2.
  • the microcurrent supplied to the human body has a negative phase, as shown in the microcurrent graphs P1-P2 of FIG. 6.
  • the level of microcurrent supplied to the human body is different for each human body because the skin resistance is different for each human body. Therefore, in order to increase the effect of massage or treatment, a microcurrent within a certain level range must be supplied, thereby raising the necessity of checking the level of the microcurrent actually supplied to the human body.
  • the microcurrent output unit 330a has a configuration capable of controlling the level of the microcurrent supplied to the human body by checking the level of the microcurrent recovered through the human body contact terminals P1 and P2.
  • the supply level confirmation signal MC may send a microcurrent flowing through the resistors R8 and R9 to the control unit 310a and is distributed through voltage distribution of the resistors R8 and R9 as shown in FIG. 5. It is also possible to use the supplied voltage level as the supply level confirmation signal MC.
  • the supply level confirmation signal MC is provided to the control chip U2 of the control unit 310a, and when the supply level confirmation signal MC is provided, the control unit 310a analyzes the supply level confirmation signal MC to the human body. It is confirmed whether the level of the microcurrent actually supplied is the desired level.
  • the boosting unit 320a is boosted through the third control signal S3.
  • the level of the voltage VC is controlled.
  • the level of the boosted voltage VC When the level of the boosted voltage VC is controlled, the level of the microcurrent actually supplied to the human body through the human body contact terminals P1 and P2 is changed, and the control through the control unit 310a is controlled by the human body. The level of microcurrent actually supplied is continued until the desired level range is reached.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Finger-Pressure Massage (AREA)

Abstract

La présente invention concerne une "beoseon" (chaussette) qui se porte au pied d'un être humain à des fins de traitement ou de massage, Elle concerne plus particulièrement une "beoseon" utilisée pour une stimulation par microcourant, qui transmet un microcourant au pied accentuant ainsi l'effet du massage ou du traitement. Cette beoseon" de stimulation par microcourant comprend: une doublure et une couche extérieure confectionnées en forme de pied humain et constituées d'un matériau non conducteur; un espace de rétention d'air créé entre la doublure et la couche extérieure; une partie d'injection d'air relié par un tuyau souple à l'espace de rétention d'air pour y injecter de l'air; plusieurs éléments de stimulation collés à la surface intérieure de la doublure et constitués d'un matériau conducteur; et un générateur de microcourant relié électriquement aux éléments de stimulation pour les alimenter en microcourant.
PCT/KR2010/003505 2009-06-01 2010-06-01 Beoseon destinée à une stimulation par microcourant WO2010140816A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR10-2009-0048132 2009-06-01
KR20090048132 2009-06-01
KR10-2010-0051318 2010-05-31
KR1020100051318A KR101235789B1 (ko) 2009-06-01 2010-05-31 미세전류 자극용 버선

Publications (2)

Publication Number Publication Date
WO2010140816A2 true WO2010140816A2 (fr) 2010-12-09
WO2010140816A3 WO2010140816A3 (fr) 2011-04-21

Family

ID=43298301

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2010/003505 WO2010140816A2 (fr) 2009-06-01 2010-06-01 Beoseon destinée à une stimulation par microcourant

Country Status (1)

Country Link
WO (1) WO2010140816A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107114827A (zh) * 2017-07-08 2017-09-01 海宁新兰迪袜业有限公司 一种新型袜子结构

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990046112A (ko) * 1999-03-24 1999-06-25 이승헌 발열체를이용한찜질버선
KR200185812Y1 (ko) * 2000-01-03 2000-06-15 이승헌 전기발열체를 이용한 찜질버선구조
KR200367040Y1 (ko) * 2004-08-17 2004-11-09 김종곤 족욕 신발
KR100558764B1 (ko) * 2005-12-08 2006-03-10 주식회사 지맨 기능성 신발
KR100778061B1 (ko) * 2006-08-22 2007-11-29 경북대학교 산학협력단 다한증 전기치료기

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990046112A (ko) * 1999-03-24 1999-06-25 이승헌 발열체를이용한찜질버선
KR200185812Y1 (ko) * 2000-01-03 2000-06-15 이승헌 전기발열체를 이용한 찜질버선구조
KR200367040Y1 (ko) * 2004-08-17 2004-11-09 김종곤 족욕 신발
KR100558764B1 (ko) * 2005-12-08 2006-03-10 주식회사 지맨 기능성 신발
KR100778061B1 (ko) * 2006-08-22 2007-11-29 경북대학교 산학협력단 다한증 전기치료기

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107114827A (zh) * 2017-07-08 2017-09-01 海宁新兰迪袜业有限公司 一种新型袜子结构

Also Published As

Publication number Publication date
WO2010140816A3 (fr) 2011-04-21

Similar Documents

Publication Publication Date Title
KR101235788B1 (ko) 미세전류 자극용 아대
EP3740278B1 (fr) Appareil de stimulation électrique
US6226552B1 (en) Neuromuscular electrical stimulation for preventing deep vein thrombosis
US6507757B1 (en) Apparatus for electrical stimulation of the body
US3083712A (en) Device for producing electrical muscle trerapy
CN201625339U (zh) 康复治疗装置
KR100994208B1 (ko) 미세전류 자극용 양말
EP2575962A2 (fr) Dispositif et système de stimulation électrique fonctionnelle et leur utilisation
CA2652565A1 (fr) Ensembles portables, systemes et procedes permettant de fournir une neurostimulation fonctionnelle ou therapeutique
KR101040683B1 (ko) 무릎관절 치료 아대
WO2011118918A2 (fr) Chaussette de stimulation par micro-courant
KR101235789B1 (ko) 미세전류 자극용 버선
KR101235783B1 (ko) 미세전류 자극용 복대
WO2011016627A2 (fr) Semelle intérieure renfermant un dispositif de stimulation par micro-‌courants
CN201431704Y (zh) 基于人体行走模式的功能性低频电刺激治疗装置
KR101235786B1 (ko) 미세전류 자극용 거들
KR20120099925A (ko) 자극패치를 가진 미세전류자극장치
KR101235784B1 (ko) 미세전류 자극용 매트
WO2010140818A2 (fr) Bande abdominale de stimulation par microcourant
CN109475739B (zh) 电刺激治疗仪
KR101235790B1 (ko) 미세전류 자극용 신발
KR100995614B1 (ko) 미세전류발생장치
WO2010140816A2 (fr) Beoseon destinée à une stimulation par microcourant
WO2011014021A2 (fr) Chaussure destinée à la stimulation d’un microcourant
WO2010140820A2 (fr) Dispositif de protection de stimulation par microcourant

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10783565

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 14.03.2012)

122 Ep: pct application non-entry in european phase

Ref document number: 10783565

Country of ref document: EP

Kind code of ref document: A2